284 related articles for article (PubMed ID: 21487653)
1. A human laboratory study of the effects of quetiapine on subjective intoxication and alcohol craving.
Ray LA; Chin PF; Heydari A; Miotto K
Psychopharmacology (Berl); 2011 Oct; 217(3):341-51. PubMed ID: 21487653
[TBL] [Abstract][Full Text] [Related]
2. Quetiapine improves response inhibition in alcohol dependent patients: a placebo-controlled pilot study.
Moallem N; Ray LA
Pharmacol Biochem Behav; 2012 Jan; 100(3):490-3. PubMed ID: 22037407
[TBL] [Abstract][Full Text] [Related]
3. A double-blind, placebo-controlled pilot trial of quetiapine for the treatment of Type A and Type B alcoholism.
Kampman KM; Pettinati HM; Lynch KG; Whittingham T; Macfadden W; Dackis C; Tirado C; Oslin DW; Sparkman T; O'Brien CP
J Clin Psychopharmacol; 2007 Aug; 27(4):344-51. PubMed ID: 17632217
[TBL] [Abstract][Full Text] [Related]
4. A double-blind, placebo-controlled trial to assess the efficacy of quetiapine fumarate XR in very heavy-drinking alcohol-dependent patients.
Litten RZ; Fertig JB; Falk DE; Ryan ML; Mattson ME; Collins JF; Murtaugh C; Ciraulo D; Green AI; Johnson B; Pettinati H; Swift R; Afshar M; Brunette MF; Tiouririne NA; Kampman K; Stout R;
Alcohol Clin Exp Res; 2012 Mar; 36(3):406-16. PubMed ID: 21950727
[TBL] [Abstract][Full Text] [Related]
5. A randomized, double-blind, placebo-controlled trial of quetiapine in patients with bipolar disorder, mixed or depressed phase, and alcohol dependence.
Brown ES; Davila D; Nakamura A; Carmody TJ; Rush AJ; Lo A; Holmes T; Adinoff B; Caetano R; Swann AC; Sunderajan P; Bret ME
Alcohol Clin Exp Res; 2014 Jul; 38(7):2113-8. PubMed ID: 24976394
[TBL] [Abstract][Full Text] [Related]
6. A human laboratory study investigating the effects of quetiapine on marijuana withdrawal and relapse in daily marijuana smokers.
Cooper ZD; Foltin RW; Hart CL; Vosburg SK; Comer SD; Haney M
Addict Biol; 2013 Nov; 18(6):993-1002. PubMed ID: 22741619
[TBL] [Abstract][Full Text] [Related]
7. The effects of quetiapine on sleep in recovering alcohol-dependent subjects: a pilot study.
Chakravorty S; Hanlon AL; Kuna ST; Ross RJ; Kampman KM; Witte LM; Perlis ML; Oslin DW
J Clin Psychopharmacol; 2014 Jun; 34(3):350-4. PubMed ID: 24747978
[TBL] [Abstract][Full Text] [Related]
8. A double-blind, placebo-controlled, randomized pilot study comparing quetiapine with placebo, associated to naltrexone, in the treatment of alcohol-dependent patients.
Guardia J; Roncero C; Galan J; Gonzalvo B; Burguete T; Casas M
Addict Behav; 2011 Mar; 36(3):265-9. PubMed ID: 21146937
[TBL] [Abstract][Full Text] [Related]
9. A randomized, double-blind, placebo-controlled add-on trial of quetiapine in outpatients with bipolar disorder and alcohol use disorders.
Brown ES; Garza M; Carmody TJ
J Clin Psychiatry; 2008 May; 69(5):701-5. PubMed ID: 18312058
[TBL] [Abstract][Full Text] [Related]
10. Effects of Alcohol Cue Reactivity on Subsequent Treatment Outcomes Among Treatment-Seeking Individuals with Alcohol Use Disorder: A Multisite Randomized, Double-Blind, Placebo-Controlled Clinical Trial of Varenicline.
Miranda R; O'Malley SS; Treloar Padovano H; Wu R; Falk DE; Ryan ML; Fertig JB; Chun TH; Muvvala SB; Litten RZ
Alcohol Clin Exp Res; 2020 Jul; 44(7):1431-1443. PubMed ID: 32363592
[TBL] [Abstract][Full Text] [Related]
11. Quetiapine for the treatment of alcoholism: scientific rationale and review of the literature.
Ray LA; Heydari A; Zorick T
Drug Alcohol Rev; 2010 Sep; 29(5):568-75. PubMed ID: 20887583
[TBL] [Abstract][Full Text] [Related]
12. Extended-release quetiapine as adjunct to an antidepressant in patients with major depressive disorder: results of a randomized, placebo-controlled, double-blind study.
Bauer M; Pretorius HW; Constant EL; Earley WR; Szamosi J; Brecher M
J Clin Psychiatry; 2009 Apr; 70(4):540-9. PubMed ID: 19358791
[TBL] [Abstract][Full Text] [Related]
13. Quetiapine in patients with schizophrenia. A high- and low-dose double-blind comparison with placebo. Seroquel Study Group.
Small JG; Hirsch SR; Arvanitis LA; Miller BG; Link CG
Arch Gen Psychiatry; 1997 Jun; 54(6):549-57. PubMed ID: 9193196
[TBL] [Abstract][Full Text] [Related]
14. Moderation of Prazosin's Efficacy by Alcohol Withdrawal Symptoms.
Sinha R; Wemm S; Fogelman N; Milivojevic V; Morgan PM; Angarita GA; Hermes G; Fox HC
Am J Psychiatry; 2021 May; 178(5):447-458. PubMed ID: 33207935
[TBL] [Abstract][Full Text] [Related]
15. Extended-release quetiapine fumarate (quetiapine XR) as adjunctive therapy in major depressive disorder (MDD) in patients with an inadequate response to ongoing antidepressant treatment: a multicentre, randomized, double-blind, placebo-controlled study.
El-Khalili N; Joyce M; Atkinson S; Buynak RJ; Datto C; Lindgren P; Eriksson H
Int J Neuropsychopharmacol; 2010 Aug; 13(7):917-32. PubMed ID: 20175941
[TBL] [Abstract][Full Text] [Related]
16. Craving and subjective responses to alcohol administration: validation of the desires for alcohol questionnaire in the human laboratory.
Courtney KE; Ashenhurst J; Bacio G; Moallem N; Bujarski S; Hartwell E; Ray LA
J Stud Alcohol Drugs; 2013 Sep; 74(5):797-802. PubMed ID: 23948540
[TBL] [Abstract][Full Text] [Related]
17. Quetiapine in relapse prevention in alcoholics suffering from craving and affective symptoms: a case series.
Croissant B; Klein O; Gehrlein L; Kniest A; Hermann D; Diehl A; Mann K
Eur Psychiatry; 2006 Dec; 21(8):570-3. PubMed ID: 17161284
[TBL] [Abstract][Full Text] [Related]
18. Development of the Neuroimmune Modulator Ibudilast for the Treatment of Alcoholism: A Randomized, Placebo-Controlled, Human Laboratory Trial.
Ray LA; Bujarski S; Shoptaw S; Roche DJ; Heinzerling K; Miotto K
Neuropsychopharmacology; 2017 Aug; 42(9):1776-1788. PubMed ID: 28091532
[TBL] [Abstract][Full Text] [Related]
19. A double-blind evaluation of gabapentin on alcohol effects and drinking in a clinical laboratory paradigm.
Myrick H; Anton R; Voronin K; Wang W; Henderson S
Alcohol Clin Exp Res; 2007 Feb; 31(2):221-7. PubMed ID: 17250613
[TBL] [Abstract][Full Text] [Related]
20. Reduction of opioid-withdrawal symptoms with quetiapine.
Pinkofsky HB; Hahn AM; Campbell FA; Rueda J; Daley DC; Douaihy AB
J Clin Psychiatry; 2005 Oct; 66(10):1285-8. PubMed ID: 16259542
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
